Orforglipron also reduced blood sugar levels in participants with type 2 diabetes
A significant trial of a daily weight-loss pill has found that it helped people to shed the pounds and reduce their blood sugar levels, making it a contender to join the new wave of drugs that combat obesity and diabetes.
People who took a 36mg pill of orforglipron lost an average of 7.3kg (16lbs) over nine months, according to results from a phase 3 clinical trial reported by the drug’s manufacturer, Eli Lilly, on Thursday.
About Author
More Stories
EU targets US aircraft and car exports in new list of potential tariffs
Will the Catholic church turn right or left? The factions lobbying to shape conclave
Irish broadcaster requests discussion over Israel’s Eurovision participation